Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
April 2002
Features
Clinical Update: Oncology Pharmaceuticals
Dr. Goldenberg presents recent studies on various cancers and the implications of new and existing therapies.
Marvin M. Goldenberg, PhD
Drug Shortages (4-Part Series)
Part 3: ISMP Drug Shortages Survey: Proactive Guidelines to Safely Manage Scarce Supplies
The results of the ISMP’s recent national survey on drug shortages are discussed, along with guidelines on how to handle drug shortages.
Matthew Grissinger, RPh
Pharmaceutical Spotlight: Recombinant Human Activated Protein C (rhAPC) or Drotrecogin Alfa (Activated)
This article focuses on the revolutionary new drug
that combats a highly complicated disease: sepsis.
Michelle Leady, PharmD, Michael Kraft PharmD, and Cesar Alaniz, PharmD
Proton Pump Inhibitor Attitudes and Usage: A Patient Survey
Despite the widely held belief that therapy with PPIs renders patients asymptomatic, breakthrough symptoms are common.
Malcom Robinson, MD and Kimberly Shaw, BA
Measuring Patients’ Health-Related Quality of Life: Practical Considerations for Implementing an Outcomes Management Program
Patient self-administered questionnaires could help determine health-related quality of life in outcomes management.
Jennifer Lofland, PharmD
Guest Commentary
The FDA and a Plea for Placebos
Is a placebo-controlled trial ethical if an effective treatment has already been established? The author discusses the issue with Robert Temple, MD.
Miriam Reisman
Departments
Editorial
Sepsis Segue
Editor-in-Chief David B. Nash discusses what is
needed for an effective “Sepsis Segue.”
David Nash, MD, MBA
Prescription Washington
The FTC and Patent Wars
Stephen Barlas
Newsletter Exchange
